Children Hospital of Philadelphia

World’s Best Hospitals in The USA

Children Hospital of Philadelphia

Children’s Hospital of Philadelphia (CHOP) is a renowned paediatric medical facility located in Philadelphia, Pennsylvania, USA. Founded in 1855 , it was the first hospital devoted to Children’s Care.

Children’s Hospital of Philadelphia is consistently ranked among the top children’s hospitals in the United States and is recognized for its excellence in paediatric healthcare, research, and education.

The hospital provides a wide range of specialised services and multidisciplinary care for children and adolescents, including advanced diagnostics, innovative treatments, and comprehensive support for patients and their families. CHOP’s commitment to delivering exceptional care has made it a leading institution in paediatric medicine.

Best Known For:

The Children’s Hospital of Philadelphia (CHOP) is best known for its expertise and achievements in several areas of pediatric healthcare. Some of the notable areas for which CHOP is renowned include:

Paediatric Specialties: CHOP is known for its extensive range of pediatric specialties, covering virtually every aspect of child health. It excels in providing specialized care for complex medical conditions, including cardiology, oncology, neurology, orthopedics, gastroenterology, and many others.

Research and Innovation: CHOP is a leader in pediatric research and has made significant contributions to advancing medical knowledge and treatment options. It has a robust research program, collaborating with leading scientists and institutions to drive discoveries and improve outcomes for children.

Cancer Care: CHOP is highly regarded for its comprehensive and advanced cancer care services. The hospital has specialized oncology teams that provide cutting-edge treatments, clinical trials, and supportive care for children with various forms of cancer.

Surgical Excellence: CHOP’s surgical teams are renowned for their expertise in performing complex pediatric surgeries. The hospital has achieved remarkable success in areas such as organ transplantation, neurosurgery, cardiovascular surgery, and minimally invasive procedures.

Patient and Family-Centered Care: CHOP prioritizes a patient and family-centered approach to care, ensuring that children and their families receive comprehensive support and involvement in the decision-making process. The hospital’s dedication to creating a caring and compassionate environment sets it apart.

Breakthroughs in the Medical field:

1922: CHOP opens its first research laboratory in a single room in the hospital’s basement.
1936: The pertussis (or whooping cough) vaccine is developed in 1936. The whooping cough vaccine was the first in a series of vaccines developed by CHOP that have had a global impact on childhood disease.
1940: CHOP establishes the nation’s first virus diagnostic laboratory in 1940. The sciences of bacteriology, virology, immunology, biochemistry, and epidemiology are then integrated into a dynamic program of research, education, and clinical care at CHOP.
1963: Dr. Stanley Plotkin, the first Division Chief of Infectious Diseases, develops the rubella (German measles) vaccine in 1963, which is now used globally.
1965: The Clinical Research Center (CRC) was established in 1965 for the study of difficult-to-diagnose paediatric diseases and the development of advanced treatments.
1967: Drs. Werner and Henle discovered that the Epstein-Barr virus (EBV) causes infectious mononucleosis, demonstrating that a common virus can cause disease.
1983: Dr. Charles Stanley and colleagues discovered MCADD (medium-chain acyl-coA dehydrogenase deficiency) in 1983, an inherited disease that can go unnoticed until it causes childhood brain damage or death.
1995: Dr. N. Scott Adzick leads the development of the Richard D. Wood Jr. Centre for Foetal Diagnosis and Treatment in 1995, which is at the forefront of foetal research and clinical practice.
2006: RotaTeq®, a vaccine for the prevention of rotavirus gastroenteritis (a severe stomach virus in infants) co-invented by Drs. Paul Offit, Stanley Plotkin, and Fred Clark, was approved by the Centers for Disease Control and Prevention in 2006.
2012: Dr. Stephan Grupp and colleagues treated the first paediatric patient with relapsed acute lymphoblastic leukaemia with CAR T-cell therapy in 2012.
2019: Drs. Yoav Dori and Hakon Hakonarson use an existing melanoma drug to treat a genetic mutation that causes severe lymphatic leakage.

MediPocket USA and Children’s Hospital of Philadelphia:

MediPocket USA, in its pursuit of sustainable healthcare for patients in India, has formed a valuable partnership with the renowned Children’s Hospital of Philadelphia (CHOP). This collaboration signifies a commitment to delivering world-class paediatric healthcare solutions to all the patients, right in their own country. By leveraging the expertise and resources of CHOP, MediPocket USA aims to bridge the gap in specialised care for children in India.

This partnership enables Indian patients to access cutting-edge treatments, advanced diagnostics, and specialised paediatric services that were previously limited to international travel. Through sustainable healthcare practices, MediPocket USA and CHOP are dedicated to improving the lives of children in India and providing them with the best possible care, right in their own communities.

Together, they are reshaping the landscape of paediatric healthcare in India and empowering families with hope and quality care. Contact US